Artículos de revistas sobre el tema "HIPPO-PATHWAY-YAP"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "HIPPO-PATHWAY-YAP".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Matthaios, Dimitrios, Maria Tolia, Davide Mauri, Konstantinos Kamposioras y Michalis Karamouzis. "YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango". Biomedicines 9, n.º 12 (20 de diciembre de 2021): 1949. http://dx.doi.org/10.3390/biomedicines9121949.
Texto completoSalem y Hansen. "The Hippo Pathway in Prostate Cancer". Cells 8, n.º 4 (23 de abril de 2019): 370. http://dx.doi.org/10.3390/cells8040370.
Texto completoAgarinis, C., V. Orsini, P. Megel, Y. Abraham, H. Yang, C. Mickanin, V. Myer, T. Bouwmeester, J. S. Tchorz y C. N. Parker. "Activation of Yap-Directed Transcription by Knockdown of Conserved Cellular Functions". Journal of Biomolecular Screening 21, n.º 3 (2 de diciembre de 2015): 269–76. http://dx.doi.org/10.1177/1087057115617906.
Texto completoGrijalva, James L., Megan Huizenga, Kaly Mueller, Steven Rodriguez, Joseph Brazzo, Fernando Camargo, Ghazaleh Sadri-Vakili y Khashayar Vakili. "Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration". American Journal of Physiology-Gastrointestinal and Liver Physiology 307, n.º 2 (15 de julio de 2014): G196—G204. http://dx.doi.org/10.1152/ajpgi.00077.2014.
Texto completoYang, Haitang, Sean R. R. Hall, Beibei Sun, Liang Zhao, Yanyun Gao, Ralph A. Schmid, Swee T. Tan, Ren-Wang Peng y Feng Yao. "NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma". Cancers 13, n.º 7 (29 de marzo de 2021): 1561. http://dx.doi.org/10.3390/cancers13071561.
Texto completoHuang, Shiyuan, Xiaona Wang, Xinmei Wu, Jiale Yu, JinJing Li, Xiaoyuan Huang, Chunfang Zhu y Hongshan Ge. "Yap regulates mitochondrial structural remodeling during myoblast differentiation". American Journal of Physiology-Cell Physiology 315, n.º 4 (1 de octubre de 2018): C474—C484. http://dx.doi.org/10.1152/ajpcell.00112.2018.
Texto completoJagannathan, Radhika, Gregory V. Schimizzi, Kun Zhang, Andrew J. Loza, Norikazu Yabuta, Hitoshi Nojima y Gregory D. Longmore. "AJUBA LIM Proteins Limit Hippo Activity in Proliferating Cells by Sequestering the Hippo Core Kinase Complex in the Cytosol". Molecular and Cellular Biology 36, n.º 20 (25 de julio de 2016): 2526–42. http://dx.doi.org/10.1128/mcb.00136-16.
Texto completoHöffken, Verena, Anke Hermann, Hermann Pavenstädt y Joachim Kremerskothen. "WWC Proteins: Important Regulators of Hippo Signaling in Cancer". Cancers 13, n.º 2 (15 de enero de 2021): 306. http://dx.doi.org/10.3390/cancers13020306.
Texto completoThaventhiran, James, Anja Hoffmann y Douglas Fearon. "CTLA-4 activates the hippo pathway to regulate terminal differentiation of the CD8+ T cell. (46.17)". Journal of Immunology 186, n.º 1_Supplement (1 de abril de 2011): 46.17. http://dx.doi.org/10.4049/jimmunol.186.supp.46.17.
Texto completoCasati, G., L. Giunti, A. Iorio, A. Marturano y I. Sardi. "P04.20 The role of YAP in Glioblastoma cell lines". Neuro-Oncology 23, Supplement_2 (1 de septiembre de 2021): ii22—ii23. http://dx.doi.org/10.1093/neuonc/noab180.074.
Texto completoWerneburg, Nathan, Gregory J. Gores y Rory L. Smoot. "The Hippo Pathway and YAP Signaling: Emerging Concepts in Regulation, Signaling, and Experimental Targeting Strategies With Implications for Hepatobiliary Malignancies". Gene Expression 20, n.º 1 (12 de junio de 2020): 67–74. http://dx.doi.org/10.3727/105221619x15617324583639.
Texto completoWong, Jenny S., Kristin Meliambro, Justina Ray y Kirk N. Campbell. "Hippo signaling in the kidney: the good and the bad". American Journal of Physiology-Renal Physiology 311, n.º 2 (1 de agosto de 2016): F241—F248. http://dx.doi.org/10.1152/ajprenal.00500.2015.
Texto completoZhou, Wenyi y Mingyi Zhao. "How Hippo Signaling Pathway Modulates Cardiovascular Development and Diseases". Journal of Immunology Research 2018 (2018): 1–8. http://dx.doi.org/10.1155/2018/3696914.
Texto completoKim, Yong Joon, Eunji Jung, Eunbie Shin, Sin-Hyoung Hong, Hui Su Jeong, Gayeong Hur, Hye Yun Jeong et al. "Genome-wide RNA interference screening reveals a COPI-MAP2K3 pathway required for YAP regulation". Proceedings of the National Academy of Sciences 117, n.º 33 (3 de agosto de 2020): 19994–20003. http://dx.doi.org/10.1073/pnas.1915387117.
Texto completoSong, Yong, Jing Fu, Min Zhou, Li Xiao, Xue Feng, Hengxi Chen y Wei Huang. "Activated Hippo/Yes-Associated Protein Pathway Promotes Cell Proliferation and Anti-apoptosis in Endometrial Stromal Cells of Endometriosis". Journal of Clinical Endocrinology & Metabolism 101, n.º 4 (1 de abril de 2016): 1552–61. http://dx.doi.org/10.1210/jc.2016-1120.
Texto completoKoinis, Filippos, Evangelia Chantzara, Michael Samarinas, Anastasia Xagara, Zisis Kratiras, Vasiliki Leontopoulou y Athanasios Kotsakis. "Emerging Role of YAP and the Hippo Pathway in Prostate Cancer". Biomedicines 10, n.º 11 (7 de noviembre de 2022): 2834. http://dx.doi.org/10.3390/biomedicines10112834.
Texto completoAhmad, Usama Sharif, Jutamas Uttagomol y Hong Wan. "The Regulation of the Hippo Pathway by Intercellular Junction Proteins". Life 12, n.º 11 (5 de noviembre de 2022): 1792. http://dx.doi.org/10.3390/life12111792.
Texto completoLiu, Yuchen, Xiaohui Wang y Yingzi Yang. "Hepatic Hippo signaling inhibits development of hepatocellular carcinoma". Clinical and Molecular Hepatology 26, n.º 4 (1 de octubre de 2020): 742–50. http://dx.doi.org/10.3350/cmh.2020.0178.
Texto completoGujral, Taranjit S. y Marc W. Kirschner. "Hippo pathway mediates resistance to cytotoxic drugs". Proceedings of the National Academy of Sciences 114, n.º 18 (17 de abril de 2017): E3729—E3738. http://dx.doi.org/10.1073/pnas.1703096114.
Texto completoFu, David, Xiangmin Lv, Guohua Hua, Chunbo He, Jixin Dong, Subodh M. Lele, David Wan-Cheng Li, Qiongli Zhai, John S. Davis y Cheng Wang. "YAP regulates cell proliferation, migration, and steroidogenesis in adult granulosa cell tumors". Endocrine-Related Cancer 21, n.º 2 (3 de enero de 2014): 297–310. http://dx.doi.org/10.1530/erc-13-0339.
Texto completoKim, Nam-Gyun y Barry M. Gumbiner. "Adhesion to fibronectin regulates Hippo signaling via the FAK–Src–PI3K pathway". Journal of Cell Biology 210, n.º 3 (27 de julio de 2015): 503–15. http://dx.doi.org/10.1083/jcb.201501025.
Texto completoHuang, Yunying, Usama Sharif Ahmad, Ambreen Rehman, Jutamas Uttagomol y Hong Wan. "YAP Inhibition by Verteporfin Causes Downregulation of Desmosomal Genes and Proteins Leading to the Disintegration of Intercellular Junctions". Life 12, n.º 6 (26 de mayo de 2022): 792. http://dx.doi.org/10.3390/life12060792.
Texto completoLuo, Jiaqian y Fa-Xing Yu. "GPCR-Hippo Signaling in Cancer". Cells 8, n.º 5 (8 de mayo de 2019): 426. http://dx.doi.org/10.3390/cells8050426.
Texto completoChuang, Linda y Yoshiaki Ito. "The Multiple Interactions of RUNX with the Hippo–YAP Pathway". Cells 10, n.º 11 (28 de octubre de 2021): 2925. http://dx.doi.org/10.3390/cells10112925.
Texto completoMougel, G., G. Mondielli, R. Appay, A. Querdray, C. Roche, A. Jijon, I. Konstantinova, A. Soude, T. Graillon y A. Barlier. "P18.07.A Hippo signaling pathway is strongly involved in meningioma tumorigenesis". Neuro-Oncology 24, Supplement_2 (1 de septiembre de 2022): ii95. http://dx.doi.org/10.1093/neuonc/noac174.334.
Texto completoBednarski, Igor Aleksander, Magdalena Ciążyńska, Karolina Wódz, Izabela Dróżdż, Małgorzata Skibińska, Joanna Narbutt y Aleksandra Lesiak. "Hippo Signaling Pathway as a New Potential Target in Non-Melanoma Skin Cancers: A Narrative Review". Life 11, n.º 7 (12 de julio de 2021): 680. http://dx.doi.org/10.3390/life11070680.
Texto completoNouri, Kazem, Taha Azad, Min Ling, Helena J. Janse van Rensburg, Alexander Pipchuk, He Shen, Yawei Hao, Jianmin Zhang y Xiaolong Yang. "Identification of Celastrol as a Novel YAP-TEAD Inhibitor for Cancer Therapy by High Throughput Screening with Ultrasensitive YAP/TAZ–TEAD Biosensors". Cancers 11, n.º 10 (19 de octubre de 2019): 1596. http://dx.doi.org/10.3390/cancers11101596.
Texto completoJi, Xinyan, Lihua Song, Li Sheng, Anhui Gao, Yang Zhao, Shixun Han, Yuchao Zhang et al. "Cyclopeptide RA-V Inhibits Organ Enlargement and Tumorigenesis Induced by YAP Activation". Cancers 10, n.º 11 (16 de noviembre de 2018): 449. http://dx.doi.org/10.3390/cancers10110449.
Texto completoFeng, Chen, Bruce Song y Xiyang Peng. "Research Progress of Hippo-Yap/Taz Signaling in Skeletal Muscle Hypertrophy". Current Research in Medical Sciences 2, n.º 1 (marzo de 2023): 37–47. http://dx.doi.org/10.56397/crms.2023.03.06.
Texto completoHabbig, Sandra, Malte P. Bartram, Roman U. Müller, Ricarda Schwarz, Nikolaos Andriopoulos, Shuhua Chen, Josef G. Sägmüller et al. "NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway". Journal of Cell Biology 193, n.º 4 (9 de mayo de 2011): 633–42. http://dx.doi.org/10.1083/jcb.201009069.
Texto completoShin, Eunbie y Joon Kim. "The potential role of YAP in head and neck squamous cell carcinoma". Experimental & Molecular Medicine 52, n.º 8 (agosto de 2020): 1264–74. http://dx.doi.org/10.1038/s12276-020-00492-9.
Texto completoMa, Xianjue, Hongxiang Wang, Jiansong Ji, Wenyan Xu, Yihao Sun, Wenzhe Li, Xiaoping Zhang, Juxiang Chen y Lei Xue. "Hippo signaling promotes JNK-dependent cell migration". Proceedings of the National Academy of Sciences 114, n.º 8 (7 de febrero de 2017): 1934–39. http://dx.doi.org/10.1073/pnas.1621359114.
Texto completoAvalos-de León, Cindy G., Mónica B. Jiménez-Castro, María Eugenia Cornide-Petronio, José Gulfo, Floriana Rotondo, Jordi Gracia-Sancho, Araní Casillas-Ramírez y Carmen Peralta. "The Effect of Fibroblast Growth Factor 15 Signaling in Non-Steatotic and Steatotic Liver Transplantation from Cardiocirculatory Death". Cells 8, n.º 12 (14 de diciembre de 2019): 1640. http://dx.doi.org/10.3390/cells8121640.
Texto completoXiong, Wenjie, Shuhua Yi, Yuting Yan, Zengjun Li, Wei Liu, Rui Lv, Zhen Yu, Dehui Zou y Lugui Qiu. "Inhibiting the Hippo Signaling Pathway Key Molecule YAP Suppresses Mantle Cell Lymphoma Proliferation By Regulating Multiple Pathogenrelated Signaling Pathways". Blood 134, Supplement_1 (13 de noviembre de 2019): 2566. http://dx.doi.org/10.1182/blood-2019-129860.
Texto completoPark, Jiwon y Carsten Gram Hansen. "Cellular feedback dynamics and multilevel regulation driven by the hippo pathway". Biochemical Society Transactions 49, n.º 4 (10 de agosto de 2021): 1515–27. http://dx.doi.org/10.1042/bst20200253.
Texto completoBottini, Angel, Dennis J. Wu, Rizi Ai, Michelle Le Roux, Beatrix Bartok, Michele Bombardieri, Karen M. Doody et al. "PTPN14 phosphatase and YAP promote TGFβ signalling in rheumatoid synoviocytes". Annals of the Rheumatic Diseases 78, n.º 5 (26 de febrero de 2019): 600–609. http://dx.doi.org/10.1136/annrheumdis-2018-213799.
Texto completoJie, Lu, Wang Fan, Dai Weiqi, Zhou Yingqun, Xu Ling, Shen Miao, Cheng Ping y Guo Chuanyong. "The Hippo-Yes Association Protein Pathway in Liver Cancer". Gastroenterology Research and Practice 2013 (2013): 1–7. http://dx.doi.org/10.1155/2013/187070.
Texto completoBae, June Sung, Sun Mi Kim, Yoon Jeon, Juyeon Sim, Ji Yun Jang, Jaehyung Son, Woosol Hong, Mi Kyung Park y Ho Lee. "Loss of Mob1a/b impairs the differentiation of mouse embryonic stem cells into the three germ layer lineages". Experimental & Molecular Medicine 51, n.º 11 (noviembre de 2019): 1–12. http://dx.doi.org/10.1038/s12276-019-0342-z.
Texto completoTran, Thi Hai Yen, Dae-Wook Yang, Minchul Kim, Da-Hye Lee, Marta Gai, Ferdinando Di Cunto, Kwang-Wook Choi y Dae-Sik Lim. "Citron kinase interacts with LATS2 and inhibits its activity by occluding its hydrophobic phosphorylation motif". Journal of Molecular Cell Biology 11, n.º 11 (13 de marzo de 2019): 1006–17. http://dx.doi.org/10.1093/jmcb/mjz013.
Texto completoHori, Naoto, Kazuyuki Okada, Yuki Takakura, Hiroyuki Takano, Naoto Yamaguchi y Noritaka Yamaguchi. "Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway". Journal of Biological Chemistry 295, n.º 26 (8 de mayo de 2020): 8798–807. http://dx.doi.org/10.1074/jbc.ra120.012781.
Texto completoSantos-de-Frutos, Karla, Carmen Segrelles y Corina Lorz. "Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck". Journal of Clinical Medicine 8, n.º 12 (3 de diciembre de 2019): 2131. http://dx.doi.org/10.3390/jcm8122131.
Texto completoHilman, D. y U. Gat. "The Evolutionary History of YAP and the Hippo/YAP Pathway". Molecular Biology and Evolution 28, n.º 8 (16 de marzo de 2011): 2403–17. http://dx.doi.org/10.1093/molbev/msr065.
Texto completoZeybek, Naciye Dilara, Eylem Baysal, Ozlem Bozdemir y Esra Buber. "Hippo Signaling: A Stress Response Pathway in Stem Cells". Current Stem Cell Research & Therapy 16, n.º 7 (3 de septiembre de 2021): 824–39. http://dx.doi.org/10.2174/1574888x16666210712100002.
Texto completoKim, Youngeun, Wantae Kim, Yonghee Song, Jeong-Rae Kim, Kyungjoo Cho, Hyuk Moon, Simon Weonsang Ro et al. "Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stability". Proceedings of the National Academy of Sciences 114, n.º 18 (17 de abril de 2017): 4691–96. http://dx.doi.org/10.1073/pnas.1620306114.
Texto completoKim, Cho-Long, Sue-Hee Choi y Jung-Soon Mo. "Role of the Hippo Pathway in Fibrosis and Cancer". Cells 8, n.º 5 (16 de mayo de 2019): 468. http://dx.doi.org/10.3390/cells8050468.
Texto completoPlouffe, Steven W., Audrey W. Hong y Kun-Liang Guan. "Disease implications of the Hippo/YAP pathway". Trends in Molecular Medicine 21, n.º 4 (abril de 2015): 212–22. http://dx.doi.org/10.1016/j.molmed.2015.01.003.
Texto completoXin, Mei, Yuri Kim, Lillian B. Sutherland, Masao Murakami, Xiaoxia Qi, John McAnally, Enzo R. Porrello et al. "Hippo pathway effector Yap promotes cardiac regeneration". Proceedings of the National Academy of Sciences 110, n.º 34 (5 de agosto de 2013): 13839–44. http://dx.doi.org/10.1073/pnas.1313192110.
Texto completoSugihara, Takaaki, Hajime Isomoto, Gregory Gores y Rory Smoot. "YAP and the Hippo pathway in cholangiocarcinoma". Journal of Gastroenterology 54, n.º 6 (27 de febrero de 2019): 485–91. http://dx.doi.org/10.1007/s00535-019-01563-z.
Texto completoLee, Jihyun, Yujin Jung, Seo won Jeong, Ga Hee Jeong, Gue Tae Moon y Miri Kim. "Inhibition of Hippo Signaling Improves Skin Lesions in a Rosacea-Like Mouse Model". International Journal of Molecular Sciences 22, n.º 2 (19 de enero de 2021): 931. http://dx.doi.org/10.3390/ijms22020931.
Texto completoSileo, Pasquale, Clémence Simonin, Patricia Melnyk, Marie-Christine Chartier-Harlin y Philippe Cotelle. "Crosstalk between the Hippo Pathway and the Wnt Pathway in Huntington’s Disease and Other Neurodegenerative Disorders". Cells 11, n.º 22 (16 de noviembre de 2022): 3631. http://dx.doi.org/10.3390/cells11223631.
Texto completo